Rozenbaum Mark H, Mangen Marie-Josee J, Huijts Susanne M, van der Werf Tjip S, Postma Maarten J
Pfizer bv, Capelle a/d IJssel, The Netherlands; Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.
Julius Centre for Health Sciences and Primary Care, University Medical Centre Utrecht, Utrecht,The Netherlands.
Vaccine. 2015 Jun 22;33(28):3193-9. doi: 10.1016/j.vaccine.2015.05.001. Epub 2015 May 14.
Community-acquired pneumonia (CAP) is one of the most common acute infections associated with a substantial clinical and economic burden. There have been few studies assessing incidence rate, duration of hospitalization, and costs of hospitalized CAP by age and care-setting.
A retrospective study was conducted using a nationwide Dutch database containing healthcare claims data of 16.7 million inhabitants. Patients with at least one claim with a discharge diagnosis of CAP between January 2008 and December 2011 were selected. The main outcome measures considered were the incidence rate, duration of hospitalization, and the direct costs of hospitalized CAP stratified by age and care-setting.
In total, 195,372 CAP cases were included in the analysis resulting in an average incidence of 295 per 100,000 population per year. Sixty-three percent (123,357) of the included patients were hospitalized for 1 or more nights, of which 5.9% (n=7241) spent at least one night in the Intensive Care Unit (ICU). Overall, these 123,357 patients spent 824,985 days in the hospital of which 48,324 were spent on the ICU. The mean duration of hospitalization of ICU patients and general ward patients was 15.2 days and 6.2 days, respectively. The total costs related to all 195,372 CAP episodes during these 4 years were €711 million, with the majority (76%) occurring among those aged 50 years and older. Median (and mean) costs were dependent on age and type of care with costs ranging from €344 (€482) per episode for 0-9 year olds treated in the outpatient hospital setting up to €10,284 (€16,374) per episode for 50-64 year olds admitted to the ICU.
There is a large variation in terms of incidence, disease burden and costs across different age groups and the treatment setting. Effective interventions, targeted at older adults, to prevent pneumonia could reduce the (financial) burden due to pneumonia.
社区获得性肺炎(CAP)是最常见的急性感染之一,会带来巨大的临床和经济负担。很少有研究按年龄和护理环境评估住院CAP的发病率、住院时间和费用。
使用一个包含1670万居民医疗保健索赔数据的荷兰全国性数据库进行回顾性研究。选取了2008年1月至2011年12月期间至少有一次出院诊断为CAP的索赔记录的患者。主要结局指标包括发病率、住院时间以及按年龄和护理环境分层的住院CAP的直接费用。
总共195372例CAP病例纳入分析,每年每10万人的平均发病率为295例。纳入患者中有63%(123357例)住院1晚或更长时间,其中5.9%(n = 7241)在重症监护病房(ICU)至少住了1晚。总体而言,这123357例患者住院824985天,其中48324天在ICU。ICU患者和普通病房患者的平均住院时间分别为15.2天和6.2天。这4年中所有195372例CAP发作的总费用为7.11亿欧元,其中大部分(76%)发生在50岁及以上人群中。中位数(和平均数)费用取决于年龄和护理类型,费用范围从门诊医院环境中治疗的0至9岁儿童每次发作344欧元(482欧元)到入住ICU的50至64岁患者每次发作10284欧元(16374欧元)不等。
不同年龄组和治疗环境在发病率、疾病负担和费用方面存在很大差异。针对老年人预防肺炎的有效干预措施可以减轻肺炎带来的(经济)负担。